Literature DB >> 17638011

Mitochondrial and energetic cardiac phenotype in hypothyroid rat. Relevance to heart failure.

Yoni Athéa1, Anne Garnier, Dominique Fortin, Lahoucine Bahi, Vladimir Veksler, Renée Ventura-Clapier.   

Abstract

Changes in thyroid status are associated with profound alterations in biochemical and physiological functioning of cardiac muscle, although its impact on cardiac energy metabolism is still debated. Similarities between the changes in cardiac gene expression in pathological hypertrophy leading to heart failure and hypothyroidism prompted scientists to suggest a role for thyroid hormone status in the development of metabolic and functional alterations in this disease. We thus investigated the effects of hypothyroidism on cardiac energy metabolism. Hypothyroid state (HYPO) was induced by thyroidectomy and propyl-thio-uracyl in male rats for 3 weeks. We examined the effects of hypothyroid state on oxidative capacity and mitochondrial substrate utilization by measuring oxygen consumption of saponin permeabilized cardiac fibers, mitochondrial biogenesis by reverse transcription polymerase chain reaction and energy metabolism, and energy transfer enzymes by spectrophotometry. The results show that maximal oxidative capacity of the myocardium was decreased from 24.9 +/- 0.9 in control (CT) to 19.3 +/- 0.7 micromol O(2) min(-1) g dry weight(-1) in HYPO. However, protein content and messenger RNA (mRNA) of PGC-1alpha and mRNA of its transcription cascade that is thought to control mitochondrial content in normal myocardium and heart failure, were unchanged in HYPO. Mitochondrial utilization of glycerol-3P (-70%), malate (-45%), and octanoate (-24%) but not pyruvate was decreased in HYPO. Moreover, the creatine kinase system and energy transfer were hardly affected in HYPO. Besides, hypothyroidism decreased the activation of other signaling pathways like p38 mitogen-activated protein kinases, AMP-activated protein kinase, and calcineurin. These results show that cellular hypothyroidism can hardly account for the specific energetic alterations of heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638011      PMCID: PMC4710782          DOI: 10.1007/s00424-007-0307-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  58 in total

1.  Divergent enzyme kinetics and structural properties of the two human mitochondrial creatine kinase isoenzymes.

Authors:  U Schlattner; M Eder; M Dolder; Z A Khuchua; A W Strauss; T Wallimann
Journal:  Biol Chem       Date:  2000-11       Impact factor: 3.915

Review 2.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 3.  AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.

Authors:  Nandakumar Sambandam; Gary D Lopaschuk
Journal:  Prog Lipid Res       Date:  2003-05       Impact factor: 16.195

4.  Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy.

Authors:  A F Quigley; R M Kapsa; D Esmore; G Hale; E Byrne
Journal:  J Card Fail       Date:  2000-03       Impact factor: 5.712

5.  Hormonal regulation of multiple promoters of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene: identification of a complex hormone-response element in the ubiquitous promoter B.

Authors:  J M Weitzel; S Kutz; C Radtke; S Grott; H J Seitz
Journal:  Eur J Biochem       Date:  2001-07

6.  Thyroid hormone interacts with PPARalpha and PGC-1 during mitochondrial maturation in sheep heart.

Authors:  Timothy D McClure; Martin E Young; Heinrich Taegtmeyer; Xue-Han Ning; Norman E Buroker; Jesús López-Guisa; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-15       Impact factor: 4.733

7.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

8.  T(3) increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3.

Authors:  K R Short; J Nygren; R Barazzoni; J Levine; K S Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

Review 9.  Energy metabolism in heart failure.

Authors:  Renée Ventura-Clapier; Anne Garnier; Vladimir Veksler
Journal:  J Physiol       Date:  2003-12-05       Impact factor: 5.182

10.  Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity.

Authors:  Elvira De Sousa; Patrick Lechêne; Dominique Fortin; Benoît N'Guessan; Souad Belmadani; Xavier Bigard; Vladimir Veksler; Renée Ventura-Clapier
Journal:  Cardiovasc Res       Date:  2002-11       Impact factor: 10.787

View more
  5 in total

1.  Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.

Authors:  Outi M Hyyti; Aaron K Olson; Ming Ge; Xue-Han Ning; Norman E Buroker; Youngran Chung; Thomas Jue; Michael A Portman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

Review 2.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

3.  Cardiac ischemia/reperfusion injury is inversely affected by thyroid hormones excess or deficiency in male Wistar rats.

Authors:  Fernando A C Seara; Leonardo Maciel; Raiana A Q Barbosa; Nayana C Rodrigues; Anderson L B Silveira; Michelle P Marassi; Adriana B Carvalho; José Hamilton M Nascimento; Emerson L Olivares
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

4.  Increased Mitochondrial DNA Copy Number and Oxidative Damage in Patients with Hashimoto's Thyroiditis.

Authors:  Fatemeh Esfahanian; Mojgan Mirabdolhagh Hazaveh; Laya Hooshmand Garehbagh; Kowsar Falahati; Mitra Ataei; Mohammad Hossein Sanati; Zohreh Jadali
Journal:  Iran J Public Health       Date:  2021-08       Impact factor: 1.429

Review 5.  Role of the phosphocreatine system on energetic homeostasis in skeletal and cardiac muscles.

Authors:  Lucas Guimarães-Ferreira
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.